-
14101por Cammarota, Simona, Citarella, Anna, Manzoli, Lamberto, Flacco, Maria Elena, Parruti, Giustino“…The risk of acute hospitalization significantly increased among patients with hepatitis C virus (HCV) coinfection (adjusted IRR 1.98; 95% CI: 1.59–2.47), renal (adjusted IRR 2.27; 95% CI: 1.45–3.56), liver (adjusted IRR 2.21; 1.57–3.13) and chronic pulmonary CMs (adjusted IRR 2.31; 1.63–3.32). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14102por Delorme, Jessica, Chenaf, Chouki, Bertin, Celian, Riquelme, Marie, Eschalier, Alain, Ardid, Denis, Authier, Nicolas“…AOP correlated in CNCP OST patients with: age ≤ 40 years old, female gender, low-income status, methadone-maintained treatment, mental health disorder, hepatitis C virus (HCV) infection, and alcohol abuse disorder. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14103“…In particular, the specificity for Streptococcus pneumoniae, Mycobacterium tuberculosis complex, and hepatitis C virus were 99.8%, 96.6%, and 97.4%, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14104por Jiang, Weixi, Huang, Sirun, Teng, Hua, Wang, Peipei, Wu, Meng, Zhou, Xia, Ran, Haitao“…PARTICIPANTS: Patients with NAFLD who had a liver stiffness measurement using pSWE and TE before liver biopsy were enrolled according to the following criteria: 2×2 contingency tables can be calculated via the reported number of cases; sensitivity and specificity were excluded according to the following criteria: history of other hepatic damage, such as chronic hepatitis C, concurrent active hepatitis B infection, autoimmune hepatitis, suspicious drug usage and alcohol abuse. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14105por Pereira, Leonn M. S., Amoras, Ednelza da Silva Graça, da Silva Conde, Simone R. S., Demachki, Sâmia, Monteiro, Jaqueline C., Martins-Feitosa, Rosimar N., da Silva, Andrea N. M. R., Ishak, Ricardo, Vallinoto, Antonio C. R.“…Three SNPs (−3279C>A, −2383C>T, and −924A>G) were analyzed in groups of patients with chronic hepatitis C (CHC), active chronic hepatitis B (CHB-A), inactive chronic hepatitis B (CHB-I), and a healthy control group (CG) using real-time PCR. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14106por Blok, Joris J., Putter, Hein, Metselaar, Herold J., Porte, Robert J., Gonella, Federica, de Jonge, Jeroen, van den Berg, Aad P., van der Zande, Josephine, de Boer, Jacob D., van Hoek, Bart, Braat, Andries E.“…RESULTS: Recipient age, model for end-stage liver disease sodium, ventilatory support, diabetes mellitus, hepatocellular carcinoma, previous malignancy, hepatitis C virus antibody, hepatitis B virus antibody, perfusion fluid, and Eurotransplant donor risk index (ET-DRI) had significant impact on outcome (graft or patient survival) at 1 or multiple points in time. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14107por Adland, Emily, Jesuthasan, Gerald, Downs, Louise, Wharton, Victoria, Wilde, Gemma, McNaughton, Anna L., Collier, Jane, Barnes, Eleanor, Klenerman, Paul, Andersson, Monique, Jeffery, Katie, Matthews, Philippa C.“…BACKGROUND: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of elimination. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14108por Flores, Yvonne N, Zhang, Zuo-Feng, Bastani, Roshan, Leng, Mei, Crespi, Catherine M, Ramírez-Palacios, Paula, Stevens, Heather, Salmerón, Jorge“…The following known risk factors for liver disease/cancer were evaluated: elevated aminotransferase levels (elevated alanine aminotransferase was defined as > 40 IU/L for males and females; elevated aspartate aminotransferase was defined as > 40 IU/L for males and females), infection with hepatitis B or hepatitis C, metabolic syndrome, high total cholesterol, diabetes, obesity, abdominal obesity, and heavy alcohol use. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14109por Bamford, Connor G. G., Aranday-Cortes, Elihu, Filipe, Ines Cordeiro, Sukumar, Swathi, Mair, Daniel, Filipe, Ana da Silva, Mendoza, Juan L., Garcia, K. Christopher, Fan, Shaohua, Tishkoff, Sarah A., McLauchlan, John“…Counter-intuitively, expression of one member of the family, IFNλ4, is associated with decreased clearance of hepatitis C virus (HCV) in the human population; by contrast, a natural frameshift mutation that abrogates IFNλ4 production improves HCV clearance. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14110por Sotiropoulos, Georgios C., Spartalis, Eleftherios, Machairas, Nikolaos, Paul, Andreas, Malagó, Massimo, Neuhäuser, Markus“…Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, α-fetoprotein levels, and tumor grade. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14111por Leung, Daniel H., Wirth, Stefan, Yao, Betty B., Viani, Rolando M., Gonzalez‐Peralta, Regino P., Jonas, Maureen M., Lobritto, Steven J., Narkewicz, Michael R., Sokal, Etienne, Fortuny, Clàudia, Hsu, Evelyn K., Del Valle‐Segarra, Antonio, Zha, Jiuhong, Larsen, Lois, Liu, Li, Shuster, Diana L., Cohen, Daniel E., Rosenthal, Philip“…In adults, treatment of hepatitis C virus (HCV) infection with ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) with or without dasabuvir (DSV) and ±ribavirin (RBV) results in high rates of sustained virologic response (SVR). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14112por Aydin, Nurten Nur, Aksoy, Firdevs, Yavuz, Ilknur, Iskender, Serap, Yildirim, Arzu Altunçekic, Yildiz, Ilknur Esen, Koksal, Iftihar“…BACKGROUND: Hepatitis C virus (HCV) infection is widespread in hemodialysis patients worldwide. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14113“…The prevalence of most major comorbidities did not differ by HIV status although chronic kidney disease and chronic hepatitis C infection were more common in HIV group (P = 0.001). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14114por Diaz, Heidi Torres, Serrano, Ruth, Bowling, Jason E, Anstead, Gregory, Javeri, Heta“…Eleven patients had Hepatitis C (HCV) and one had active Hepatitis B infection. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14115“…Concurrent hepatitis B (in 5.5%) and hepatitis C (in 18.5%) were present. Clinically relapsing (10%) and cholestatic (5%) hepatitis were seen. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14116“…The overall estimate for hepatitis C incidence was 1.3/100py (95%-CI: 1.0–1.8). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14117por Salmon, Dominique, Trimoulet, Pascale, Gilbert, Camille, Solas, Caroline, Lafourcade, Eva, Chas, Julie, Piroth, Lionel, Lacombe, Karine, Katlama, Christine, Peytavin, Gilles, Aumaitre, Hugues, Alric, Laurent, Boué, François, Morlat, Philippe, Poizot-Martin, Isabelle, Billaud, Eric, Rosenthal, Eric, Naqvi, Alissa, Miailhes, Patrick, Bani-Sadr, Firouzé, Esterle, Laure, Carrieri, Patrizia, Dabis, François, Sogni, Philippe, Wittkop, Linda“…METHODS: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients starting a first direct-acting antiviral (DAA) regimen before February 2016 and included in the French ANRS CO13 HEPAVIH cohort were eligible. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14118por Nguyen, Truong Tam, Lemee, Véronique, Bollore, Karine, Vu, Hai Vinh, Lacombe, Karine, Thi, Xuan Lien Truong, Luong, Que Anh, Dubos, Charline, Plantier, Jean-Christophe, Thi, Huong Duong, Laureillard, Didier, Lemoine, Maud, Tuaillon, Edouard“…HCV RNA was detected on DBS specimens in 79 out 86 subjects with chronic hepatitis C (sensitivity 92.5%; 95% CI: 85.1–96.9%). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14119por Caso-Maestro, Oscar, Jiménez-Romero, Carlos, Justo-Alonso, Iago, Calvo-Pulido, Jorge, Lora-Pablos, David, Marcacuzco-Quinto, Alberto, Cambra-Molero, Félix, García-Sesma, Alvaro, Pérez-Flecha, Marina, Muñoz-Arce, Carlos, Loinaz-Segurola, Carmelo, Manrique-Municio, Alejandro“…We identified 5 risk factors as independent predictors of graft survival: recipient hepatitis C virus (HCV)-positivity [hazard ratio (HR) = 2.35; 95% confidence interval (CI): 1.55-3.56; P = 0.00]; recipient age (HR = 1.04; 95%CI: 1.02-1.06; P = 0.00); donor age X model for end-stage liver disease (D-MELD) (HR = 1.00; 95%CI: 1.00-1.00; P = 0.00); donor value of serum glutamic-pyruvic transaminase (HR = 1.00; 95%CI: 1.00-1.00; P = 0.00); and donor value of serum sodium (HR = 0.96; 95%CI: 0.94-0.99; P = 0.00). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14120por Wu, Feng-Hsu, Shen, Ching-Hui, Luo, Shao-Ciao, Hwang, Jen-I, Chao, Wen-Shan, Yeh, Hong-Zen, Jan, Yee-Gee, Yen, Yun, Cheng, Shao-Bin, Wu, Cheng-Chung, Lin, Yi-Ling, P’eng, Fang-Ku“…RESULT: Group B had a significantly higher incidence of associated co-morbidities and hepatitis C infection. Postoperative complication rates and 90-day mortality rates after liver resection did not differ between groups A and B (p = 0.834 and p = 1.000, respectively), though group B had a longer postoperative stay (p = 0.001). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto